AP Featured Top Story
  • Updated

New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different kind of treatment than the chemotherapy that is a mainstay for these patients. Called daraxonrasib, the drug is designed to block a mutated protein that fuels most cases of pancreatic cancer, one of the deadliest types of cancer. The research was published Sunday in the New England Journal of Medicine and presented at an American Society of Oncology meeting. Maker Revolution Medicines will seek Food and Drug Administration approval.

  • Updated

FILE - This undated microscope image from USC via the NIH shows pancreatic cancer cells, nuclei in blue, growing as a sphere encased in membranes, red. (Min Yu/Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, USC Norris Comprehensive Cancer Center, File)

  • Updated

Pope Leo XIV has visited families near Naples affected by illegal toxic dumping linked to the mafia. On Saturday, he met with those who lost loved ones to cancer and other illnesses tied to pollution. His visit to the "Land of Fires" reflects his commitment to continuing Pope Francis' environmental agenda. The European Court of Human Rights found that Italian authorities knew about the pollution since 1988 but failed to act. Bishop Antonio Di Donna emphasized the ongoing issue, urging the pope to condemn polluters. Families of victims appealed to the pope for help in healing the land.

  • Updated

Cincinnati Children's Hospital facility dog Hadley sits at the feet of 11-year-old Bethany Striggles, who recently finished a chemotherapy treatment for bone cancer, in her room at Cincinnati Children's Hospital in Cincinnati, Monday, May 4, 2026. (AP Photo/Carolyn Kaster)

Deciding when to get a routine mammogram is confusing. Guidelines disagree on whether to begin at age 40, 45 or 50, and whether a yearly or every-other-year scan is best. New research aims to one day help tailor advice by using genetics and other factors to determine whether a woman's risk of breast cancer is low, high or somewhere in between. For now, experts say talk with your doctor about factors such as cancer in the family and your own health history to decide when to start screening — and then stick with it.